Ovarian Cancer Stem Cells Identified, Characterized
 ScienceDaily (Apr. 18, 2008)  Researchers at Yale School of Medicine 
 have identified, characterized and cloned ovarian cancer stem cells 
 and have shown that these stem cells may be the source of ovarian 
 cancer's recurrence and its resistance to chemotherapy.
 
 ------------
 ----------
 See also: 
 Health & Medicine
 Stem Cells 
 Brain Tumor 
 Prostate Cancer 
 Skin Cancer 
 Cancer 
 Ovarian Cancer 
 Reference
 Embryonic stem cell 
 Metastasis 
 Stem cell treatments 
 Nanomedicine 
 "These results bring us closer to more effective and targeted 
 treatment for epithelial ovarian cancer, one of the most lethal forms 
 of cancer," said Gil Mor, M.D., associate professor in the Department 
 of Obstetrics, Gynecology & Reproductive Sciences at Yale School of 
 Medicine.
 
 Mor presented his findings recently at the annual meeting of the 
 American Association for Cancer Research (AACR) Meeting in San Diego, 
 California.
 
 Cancerous tumors are made up of cells that are both cancerous and non-
 cancerous. Within cancerous cells, there is a further subclass 
 referred to as cancer stem cells, which can replicate indefinitely.
 
 "Present chemotherapy modalities eliminate the bulk of the tumor 
 cells, but cannot eliminate a core of these cancer stem cells that 
 have a high capacity for renewal," said Mor, who is also a member of 
 the Yale Cancer Center. "Identification of these cells, as we have 
 done here, is the first step in the development of therapeutic 
 modalities."
 
 Mor and colleagues isolated cells from 80 human samples of either 
 peritoneal fluid or solid tumors. The cancer stem cells that were 
 identified were positive for traditional cancer stem cell markers 
 including CD44 and MyD88. These cells also showed a high capacity for 
 repair and self-renewal.
 
 The isolated cells formed tumors 100 percent of the time. Within 
 those tumors, 10 percent of the cells were positive for cancer stem 
 cell marker CD44, while 90 percent were CD44 negative.
 
 Mor and his team were able to isolate and clone the ovarian cancer 
 stem cells. They found that these cells were highly resistant to 
 conventional chemotherapy while the non-cancer stem cells responded 
 to treatment. "Isolating and cloning these cells will lead to 
 development of new treatments to target and eliminate the cancer stem 
 cells and hopefully prevent recurrence," said Mor.
 
 Adapted from materials provided by Yale University.
 
 Need to cite this story in your essay, paper, or report? Use one of 
 the following formats: 
  APA
 
 MLA Yale University (2008, April 18). Ovarian Cancer Stem Cells 
 Identified, Characterized. ScienceDaily. Retrieved April 22, 2008, 
 from http://www.scienced
 
 http://www.scienced
 
 
«¤»¥«¤»§«¤»¥«¤»§«¤»¥«¤»«¤»¥«¤»§«¤»¥«¤»§«¤»¥«
¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
StemCells subscribers may also be interested in these sites:
Children's Neurobiological Solutions
http://www.CNSfoundation.org/
Cord Blood Registry
http://www.CordBlood.com/at.cgi?a=150123
The CNS Healing Group
http://groups.yahoo.com/group/CNS_Healing
____________________________________________
«¤»¥«¤»§«¤»¥«¤»§«¤»¥«¤»«¤»¥«¤»§«¤»¥«¤»§«¤»¥«
¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
Change settings via the Web (Yahoo! ID required)
Change settings via email: Switch delivery to Daily Digest | Switch format to Traditional
Visit Your Group | Yahoo! Groups Terms of Use | Unsubscribe
__,_._,___
No comments:
Post a Comment